chrisvoncsefalvay/vaers-outcomes huggingface dataset:
two of his patients have had a significant increase in their total cholesterol and LDL levels a few days after receiving the BNT162B2 vaccine; two of his patients have had a significant increase in their total cholesterol and LDL levels a few days after receiving the BNT162B2 vaccine; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received bnt162b2 (BNT162B2, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Reported as that two of his patients have had a significant increase in their total cholesterol and LDL levels a few days after receiving the BNT162B2 vaccine. Pharmacist also added that these patients had no other change whether in their exercise routine or their dietary habits. They had not consumed food with large amounts of cholesterol. On an unspecified date, The patient experienced two of his patients have had a significant increase in their total cholesterol and ldl levels a few days after receiving the BNT162B2 vaccine. The patient underwent lab tests and procedures which included blood cholesterol: increase on, low density lipoprotein: increase on.  The outcome of the events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow-up (07Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101103564 same drug/AE/reporter, different pt.
myeloma; Extra dose administered; This case was reported by a pharmacist via call center representative and described the occurrence of myeloma in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 3rd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced myeloma (serious criteria GSK medically significant) and extra dose administered. The patient was treated with chemotherapy, nos (Chemotherapy) and stem cells (Stem Cell Transplant). On an unknown date, the outcome of the myeloma and extra dose administered were unknown.   It was unknown if the reporter considered the myeloma to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient received two doses of Shingrix in 2018. The patient was diagnosed with myeloma in 2019, received chemo and a stem call transplant and his oncologist ordered for him to get Shingrix again. The reporter believed the patient received another dose of Shingrix in February 2020. The health care professional had no details about first two doses of shingrix or patient DOB or initials.
Patient came to office on 6/11/18 with less than 50 vesicles on body. Dxd vaccine adverse reaction.
he was 6 feet but had shrunk a little; fever of 100.9; chills; pain around pacemaker in chest; lower back pain; had a sore arm; This is a spontaneous report from a contactable consumer (patient). An 86-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via intramuscular (lot number: 3L3246) on right arm on 05Jan2021 at single dose for covid-19 immunisation. The relevant medical history included 3 heart attacks in the past and pacemaker from an unspecified date. Concomitant medications were not reported. The patient had a reaction to the Covid vaccine he received on 05Jan2021, stated he had a sore arm the next day 06Jan2021 that had resolved. Stated last night on 07Jan2021, he had a fever of 100.9 and chills and mild pain around pacemaker area in his chest and lower back pain. Stated he treated the fever and chills and pain with Tylenol and stated it had improved. The patient stated he was 6 feet but had shrunk a little on an unspecified date. The outcome of the event had a sore arm was recovered on 07Jan2021, for the event he was 6 feet but had shrunk a little was unknown, while other events were recovering.
Patient report having local pain at vaccination site the day of vaccination. There is limited range of motion at the vaccinated area (arm does not extend above ear level). Shooting pain reported with certain actions involving vaccinated arm. Pain not relieved by analgesics or anti inflammation medication.
Narrative:  COVID infections following completion of COVID vaccine series 03/05/21 COVID vaccine dose #1 03/29/21 COVID vaccine dose #2 06/22/21 Pt reports inner ear problemx12 days that has made him very sick from vertigo 06/25/21 Pt states ear problem was treated with steroids by allergy doctor; reports dizziness, but slowly getting better and is worse with head movement; unable to hear from right ear, still has nausea on and off, no fever, speech or swallow problems, or focal weakness, c/o worsening tinnitus associated with blurred vision, and headache 07/20/21 Pt presents to ED with elevated glucose and reports n/v/d x4 days, cough, congestion, weakness, back pain and body aches, chills, fatigue, fever, headache, dyspnea; COVID POSITIVE; admitted to ICU 07/22/21 Pt transferred to stepdown 07/23/21 Pt medically stable and is discharged with rx for zinc, ondansetron, dextromethorphan/guaifenesin, ascorbic acid, albuterol, acetaminophen 07/24/21 Pt reports doing very well with very mild respiratory symptoms and fatigue, no fever 07/25/21 Pt reports headache, cough, and loss of taste or smell 07/27/21 Pt reports no symptoms and no fever for past 7 days since ER visit
Patient reported had flu shot 1 month ago December 7th.  Since that date has experienced pain, arm and finger, numbness, and lost range of motion in right arm.  X-rays done by doctor - no arthritis, no bone or shoulder injury.  Currently using heat, Tylenol and Advil.  To start physical therapy on Thursday, 01/12/2006.
ED visit for aspiration of right lower lobe. Hospital admission Acute respiratory failure with hypoxia. Patient died on 11/12/2021. ED visit, hospital admission and death within 6 weeks of receiving the COVID vaccine.
ADMINISTERED ONLY THE BUFFER PACK OF VAXCHORA; This spontaneous case (PVX2019-1551) report was received from a healthcare professional on 14-Jun-2019. It describes a 42-year-old female consumer who "administered only the buffer pack of Vaxchora". The consumer was receiving Vaxchora for an unknown indication.  Case report: The consumer administered only buffer pack of Vaxchora on 14-Jun-2019.  Action taken with Vaxchora was not applicable.   The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "administered only the buffer pack of Vaxchora" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "administered only the buffer pack of Vaxchora" was considered as not applicable.
dizziness/dizzy; little headache; felt like she had the flu/flu-like symptoms; body aches; low grade fever that never went over 101.4/low grade fever between 99.6 and 100; red rash on her chest and upper abdomen; it was diffuse not pinpoint, wasn't raised/rash was across her chest, breasts, and above her belly button, but not on her back; pain in her right arm which got stronger at the injection site overnight/sore arm; This is a spontaneous report from a contactable nurse (patient).  A 69-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL3248, expiry date: Apr2021), via an unspecified route of administration on 15Jan2021 at 12:30 at a single dose on the right arm for COVID-19 immunization.  The patient has a medical history of having covid infection in Aug2020 where her symptoms were low grade fever and headaches only. The patient also stated that when she gets a virus, she always gets this kind of rash. The patient is in an ongoing year -long antibody study where they check for antibodies every 3 months. The results of the 1st titre was 270 after her 10-day quarantine period, and in Dec2020, it was still 270. There were no concomitant medications. The patient reported that she had a sore arm on Friday, the day of the vaccination, 15Jan2021. She experienced pain in her right arm which got stronger at the injection site overnight. Then on Saturday 16Jan2021 at 11:00 AM all her symptoms started. She developed a low grade fever that never went over 101.4, a little headache, dizziness, and body aches. She stated that it was weird because she rarely gets sick, but she felt like she had the flu. She is getting a low grade fever between 99.6 and 100, flu-like symptoms and was dizzy. Then on the night of Saturday 16Jan2021, when she went to bed she had a red rash on her chest and upper abdomen; it was diffuse not pinpoint, wasn't raised. The rash was across her chest, breasts, and above her belly button, but not on her back. The patient reported that she still has the rash, and that it has actually gotten worse; it's spread more across her whole chest which is typical. Since when she gets a virus, she always gets this kind of rash; it doesn't itch; it's just kind of there and it's always in the same place whenever she gets it. The outcome of the event 'red rash on her chest and upper abdomen; it was diffuse not pinpoint, wasn't raised/rash was across her chest, breasts, and above her belly button, but not on her back' was not recovered while the outcome of the other events was unknown.
Pt received ROTATEQ vaccine on 10-24-13 and 48-72 hrs. later developed decreased po intake and diarrhea resulting in dehydration requiring a 3 day hospitalization for observation and IV fluids.
Mother calls about 45 minutes, post vax, saying that pt had urinary urgency right after getting vaccines then developed drowsiness and a stomach ache. She says he soon became flushed and "like he passed out a little". She says he's rested for 5 minutes and seems himself again. She says he feels fine but has blotches of red, everywhere and feels hot. Advised to call doctor. The doctor advised mom to give pt Benadryl and Motrin. She did this and he was better within 1 hour.
Swelling of tongue, painful, blisters on Right side of tongue, no better after 5 days. starting to improve after 2 weeks, then the left side of tongue started with bumps and pain. I took pictures.
14 days following vax pt c/o hives of the neck & face;taken to local hlth clinic, seen by MD given DPH & cortisone;
Veins on top of his biceps turned dark purple; Hhoulder soreness; A spontaneous report was received from a consumer who was a 25-year old, male patient, who received Moderna's COVID-19 vaccine and experienced veins on top of his biceps turned dark purple  The patient's medical history included soreness usually occurs when he gets his flu vaccine. The patient was not taking any concomitant medications.   On 23 DEC 2020 at 10:00, approximately 12 hours prior to the onset of the events, the patient received his first of two planned doses of mRNA-1273 intramuscularly in the left shoulder for prophylaxis of COVID-19 infection.   On 23 DEC 2020 around 22:00 to 23:00, the patient noticed the veins on top of his biceps turned dark purple and he had shoulder soreness for the next two days. He noted that the soreness normally occurs when he gets his flu vaccine. The patient was not taking any treatment for the events.   Action taken with mRNA-1273 in response to the events was not reported.    The event, veins on top of his biceps turned dark purple, was considered resolved on 25 DEC 2020. The outcome of the event, shoulder soreness, was not reported.; Reporter's Comments: This case concerns a 25 year old male subject who experienced a non-serious expected event of vein discoloration. The event occurred the same day, approximately 1 hour, of vaccination. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
There is a possibility Patient may have received 0.25 ml of vaccine rather than the recommended 0.2 ml. of the Moderna Bivalent presentation for 6 months to 5 years.  A staff member was not aware of the correct dosing of the bivalent vaccine. The system in place for drawing up vaccine and administering vaccine may have allowed for staff member to have drawn up 0.25 ml and another staff member to give the vaccine. It cannot be determined if the correct or incorrect amount was drawn up or given. There has been no reported adverse reaction from the parents to date.
I had numbness in cheeks, jaws about 1/2 hour after vaccine. I exp headache base of my skull and very tires. I woke up Fri morning wil chills, headache and fiber of my being hurt. On 2/6 got light headed felt like I was going to pass out and exp heart palpitations..Also at the injection site was warm to touch, red cherry in color and pain.I still have the discolor at the injection site now. I missed one day of work dint go to urgent care.
Fully vaccinated patient admitted through ED for COVID pneumonia and acute hypoxic respiratory failure.  Treated with dexamethason, remdesivir, zin, vit C, and vit D.  Required HFNC during day and BiPAP at night.  Discharged home on 09/02/2021 with supplemental O2.
Patient had flu and pneumonia injections Monday.  Came to office yesterday (Wednesday) with an itchy rash on face and back.  Patient also stated he had chest pains and very sleep but these symptoms were better at visit.
Itching of the throat; roof of my mouth itching; the back of my throat felt swollen and itching; Red rash at injection site the size of baseball; Red rash at injection site the size of baseball; injection arm hurting; Swelling of lower cheek; Shoulder blade pain on same side of injection arm/felt like fracture/hurt when sneezed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Swelling of lower cheek), THROAT IRRITATION (Itching of the throat), ORAL PRURITUS (roof of my mouth itching), PHARYNGEAL SWELLING (the back of my throat felt swollen and itching) and VACCINATION SITE ERYTHEMA (Red rash at injection site the size of baseball) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced SWELLING FACE (Swelling of lower cheek) and ARTHRALGIA (Shoulder blade pain on same side of injection arm/felt like fracture/hurt when sneezed). On an unknown date, the patient experienced THROAT IRRITATION (Itching of the throat), ORAL PRURITUS (roof of my mouth itching), PHARYNGEAL SWELLING (the back of my throat felt swollen and itching), VACCINATION SITE ERYTHEMA (Red rash at injection site the size of baseball), VACCINATION SITE RASH (Red rash at injection site the size of baseball) and MYALGIA (injection arm hurting). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form; HISTAMINE at a dose of 1 dosage form; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at a dose of 10 mg and IBUPROFEN at a dose of 800 mg. On 14-Apr-2021, ARTHRALGIA (Shoulder blade pain on same side of injection arm/felt like fracture/hurt when sneezed) had resolved. At the time of the report, SWELLING FACE (Swelling of lower cheek), THROAT IRRITATION (Itching of the throat), ORAL PRURITUS (roof of my mouth itching), PHARYNGEAL SWELLING (the back of my throat felt swollen and itching), VACCINATION SITE ERYTHEMA (Red rash at injection site the size of baseball), VACCINATION SITE RASH (Red rash at injection site the size of baseball) and MYALGIA (injection arm hurting) outcome was unknown.            Concomitant products included Kidney stone prevention medication for an unknown indication.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: follow up received on 02-JUN-2021.Reporter information was updated, patient demographic details was updated, treatment information was updated, events was updated , dosage information was updated.
Injection site pain started 6 hours after shot. 18 hrs after shot total body aches, fever, headache lasting 16 hrs.
This spontaneous report was received from medical assistant and refers to a patient of unknown demographics. The patient's medical history, concurrent condition, concomitant medication and drug allergies/reactions were not provided. On 23-OCT-2017, the patient was vaccinated with a properly stored but expired dose of PNEUMOVAX 23 (dose, route not provided) lot # L019835, expiry date: 23-MAR-2017 for prophylaxis. No adverse effect reported. No product quality complaint (PQC) was involved. No additional information was available.
PATIENT BECAME LIGHTHEADED, DIZZY, SWEATY, AND SLIGHTLY NAUSEATED WITHIN 1 MINUTE OF RECEIVING COVID PFIZER VACCINE. VITALS TAKEN: BP = 98/62, PULSE = 92, O2 SAT = 100%. PATIENT WAS LAID DOWN ON BENCH WITH FEET ELEVATED AND DRANK GLASS OF APPLE JUICE AND WATER. PATIENT REPORTED RELIEF OF SYMPTOMS AFTER 5-10 MINUTES OF LYING DOWN. PATIENT SAT UP IN CHAIR FOR 5 MINUTES BEFORE ALLOWED TO STAND UP AND WALK ABOUT. PATIENT APPEARRED AND REPORTED STABLE ENOUGH TO RIDE IN CAR BACK HOME.
10/21 they found out I had heart failure. 02/08/2022 I ended up getting a collapsed lung and pneumonia and that is when  they found out I had stage 4 ovarian cancer. I had a yearly physical on 04/19/2021 and everything was normal at that time. I'm still dealing with this at this time.
Started getting a little cold; Thighs were tight; Their tong was curling on the sides; Speech got a little bit slurry; Breathing hard through their mouth; Could not walk; Blood pressure went up.; Got a rash; Got the rigors, so intense/ rigors were so bad/ shaken really bad; fever came up/ 99°F/103.2°F; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Started getting a little cold), MUSCLE TIGHTNESS (Thighs were tight), SCALLOPED TONGUE (Their tong was curling on the sides), DYSARTHRIA (Speech got a little bit slurry) and DYSPNOEA (Breathing hard through their mouth) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 022M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Oct-2021, the patient experienced NASOPHARYNGITIS (Started getting a little cold), MUSCLE TIGHTNESS (Thighs were tight), SCALLOPED TONGUE (Their tong was curling on the sides), DYSARTHRIA (Speech got a little bit slurry), DYSPNOEA (Breathing hard through their mouth), GAIT DISTURBANCE (Could not walk), HYPERTENSION (Blood pressure went up.), RASH (Got a rash), CHILLS (Got the rigors, so intense/ rigors were so bad/ shaken really bad) and PYREXIA (fever came up/ 99°F/103.2°F). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form. On 24-Oct-2021, NASOPHARYNGITIS (Started getting a little cold), MUSCLE TIGHTNESS (Thighs were tight), SCALLOPED TONGUE (Their tong was curling on the sides), DYSARTHRIA (Speech got a little bit slurry), DYSPNOEA (Breathing hard through their mouth), GAIT DISTURBANCE (Could not walk), HYPERTENSION (Blood pressure went up.), RASH (Got a rash), CHILLS (Got the rigors, so intense/ rigors were so bad/ shaken really bad) and PYREXIA (fever came up/ 99°F/103.2°F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Oct-2021, Blood pressure measurement: high (High) Blood pressure went up.. On 24-Oct-2021, Body temperature: 99°f (High) first it was 99°F and then 103.2°F,it went back to 100°F. On 24-Oct-2021, Heart rate: high (High) Heart rate went up.. On 24-Oct-2021, Oxygen saturation: low (Low) The oxygen level went down.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products included thyroid medication and cholesterol medication for an unknown indication.  Treatment included Fluids.  Patient went to the ER where they administered fluids, checked them for covid-19, checked their kidneys, but is was ok.   This case was linked to MOD-2021-363314, MOD-2021-363315 (Patient Link).
Headache; This is a spontaneous report from a Pfizer Sponsored Program  A non-contactable consumer reported that a patient of unspecified age and gender received bnt162b2 (BNT162B2 lot number and expiration date were not reported) via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had a slight headache the day after getting the vaccine. Patient had no arm soreness. Patient stated that this vaccine was the best bet at getting an excellent IgG titer level without actually getting sick with Covid. Outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
This is a spontaneous report obtained from a contactable physician through a Pfizer sales representative. A female patient (age unknown) received PREVNAR 13 on an unknown date. On an unknown date, an extreme amount of swelling occurred. Patient went to the Emergency Department (ED) and followed up with her medical doctor. Follow-up (06DEC2012) Follow-up attempts completed. No further information expected.
No symtoms being reported; the patient had received 3 doses of GARDASIL 9; some of the doses were adminitered off-schedule; This spontaneous report has been received from a pharmacist, concerning a 22 year old female patient.      The patient's concurrent conditions, historical conditions, previous drug reactions, or allergies and concomitant medication were not reported.  In approximately August 2018 (also reported as "18 months ago"), the patient was vaccinated  with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, lot number, expiration date and anatomical location not reported).   In approximately October 2019 (also reported as "4 months ago"), she was vaccinated with second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, lot number, expiration date and anatomical location not reported).   Then on 08-FEB-2020 (reported as 2 days ago, 16 weeks from second dose), she received the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (lot number 1602284 has been verified to be valid, expiration date 26-SEP-2021). All the doses were adminitered as prophylaxis. In addition, some of the doses were administered off schedule (inappropriate schedule of product administration). No symptoms were reported.
8 hours post vaccine , Headache, vomiting, full arm pain, agitation,  lasting approximate  3 hrs.  Ice on arm and Advil 2x 500mg